The Past versus the Present, 1980-2004: Reduction of Mean Initial Low-Dose, Long-Term Glucocorticoid Therapy in Rheumatoid Arthritis from 10.3 to 3.6 mg/Day, Concomitant with Early Methotrexate, with Long-Term Effectiveness and Safety of Less than 5 mg/Day

By  

Neuroimmunomodulation, Vol. 22, Iss. 1-2, 2014-09 ,pp. : 89-103

Karger

Access to resources Recommend Favorite

The Long-Term Effects of Switching from Active Intravenous Bisphosphonate Treatment to Low-Dose Maintenance Therapy in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 83, Iss. 3, 2015-02 ,pp. : 183-189

Karger

Access to resources Recommend Favorite

Fracture during Intravenous Bisphosphonate Treatment in a Child with Osteogenesis Imperfecta: An Argument for a More Frequent, Low-Dose Treatment Regimen

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 3, 2013-12 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

Cardiac Effects of Low-Dose Growth Hormone Replacement Therapy in Growth Hormone-Deficient Adults

By  

Hormone Research in Paediatrics, Vol. 58, Iss. 1, 2002-08 ,pp. : 21-29

Karger

Access to resources Recommend Favorite

Recombinant versus Urinary Follicle-Stimulating Hormone in the Low-Dose Regimen in Anovulatory Patients with Polycystic Ovary Syndrome: A Safer and More Effective Treatment

By  

Hormone Research in Paediatrics, Vol. 55, Iss. 5, 2001-12 ,pp. : 224-228

Karger

Access to resources Recommend Favorite